The Value Signal — October 27, 2026

480 articles scanned · 15 high-signal

Signal Map

Executive Summary

Value-based care's revenue now hinges on scoring and data infrastructure: insurers are litigating star ratings, Big Tech is backing prior authorization reform, and Medicaid's eligibility floor is shifting beneath both.

Star Ratings have become a litigation asset. Healthcare Dive reports that Centene has sued CMS over its 2027 Medicare Advantage ratings, joining a growing pile of insurer suits seeking recalculated scores worth hundreds of millions of dollars in extra payments, even as payers face a Jan. 1 deadline to adopt new prior authorization technology. Modern Healthcare charts Humana's star ratings resurgence, a reminder that operational recovery remains the more durable path back to bonus dollars. On Prior Authorization and Interoperability, Healthcare Finance News reports that Amazon, Google and Oracle have pledged support for prior authorization reforms. Meanwhile, Leavitt Partners makes the case for modernizing ACO quality reporting with HL7 FHIR, the same standards plumbing now expected to carry both utilization management and quality measurement.

Medicaid is entering an implementation crunch. Milbank Memorial Fund distills lessons from five states on rolling out community engagement requirements, while Health Tech Nerds points to Molina and Elevance Q3 earnings as the read-through for how government-program pressure is landing on managed care balance sheets. In Rural and Kidney Care, HFMA reports that workforce initiatives captured the largest share of the $4 billion in Rural Health Transformation Program grants obligated by midsummer, and Healthcare Innovation reports that dialysis providers are responding to HHS's Kidney Care National Plan. On Value-Based Care delivery, Hospice News reports that Daymark Health's oncology palliative model reduced hospitalizations and costs, a proof point for upstream serious-illness care in risk arrangements.